Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $331.74 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $92.19 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $73.73 | 4 | $0 (2022) |
| Medtronic, Inc. | $54.19 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $30.27 | 2 | $0 (2017) |
| Abbott Laboratories | $24.15 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.68 | 1 | $0 (2017) |
| PFIZER INC. | $11.52 | 1 | $0 (2018) |
| Allergan Inc. | $11.03 | 1 | $0 (2017) |
| UCB, Inc. | $10.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.15 | 1 | Abbott Laboratories ($24.15) |
| 2022 | $108.01 | 4 | Medtronic, Inc. ($54.19) |
| 2018 | $54.04 | 3 | Novartis Pharmaceuticals Corporation ($42.52) |
| 2017 | $145.54 | 10 | Novartis Pharmaceuticals Corporation ($49.67) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Heart Failure | ||||||
| 10/18/2022 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $54.19 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/14/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/30/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/10/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/27/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/09/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/25/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/24/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 1,009 | 1,874 | $395,731 | $138,295 |
| 2022 | 6 | 755 | 1,232 | $449,943 | $102,665 |
| 2021 | 5 | 283 | 539 | $175,577 | $41,884 |
| 2020 | 6 | 192 | 308 | $92,614 | $23,765 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 377 | 915 | $167,235 | $56,184 | 33.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 261 | 563 | $134,821 | $51,946 | 38.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 155 | $53,588 | $20,675 | 38.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 95 | 97 | $37,927 | $8,588 | 22.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 129 | 144 | $2,160 | $902.33 | 41.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 321 | 649 | $229,415 | $52,893 | 23.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 188 | 194 | $72,320 | $16,129 | 22.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 130 | 266 | $66,449 | $15,047 | 22.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 79 | 79 | $54,988 | $12,504 | 22.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 30 | $23,229 | $5,279 | 22.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 14 | 14 | $3,542 | $814.10 | 23.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 114 | 275 | $93,947 | $22,336 | 23.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 52 | 147 | $34,134 | $8,374 | 24.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 78 | 78 | $27,062 | $6,426 | 23.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 26 | 26 | $17,249 | $4,002 | 23.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $3,185 | $746.46 | 23.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 63 | 133 | $32,338 | $10,781 | 33.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 93 | $16,769 | $5,164 | 30.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 44 | 44 | $10,566 | $3,715 | 35.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $5,683 | $1,825 | 32.1% |
| 49083 | Drainage of fluid from abdominal cavity using imaging guidance | Facility | 2020 | 14 | 14 | $11,830 | $1,204 | 10.2% |
| 32555 | Removal of fluid from chest cavity with imaging guidance | Facility | 2020 | 12 | 12 | $15,428 | $1,074 | 7.0% |
About Dr. Krishna Vanam, DO
Dr. Krishna Vanam, DO is a Internal Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1841636305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Krishna Vanam, DO has received a total of $331.74 in payments from pharmaceutical and medical device companies, with $24.15 received in 2023. These payments were reported across 18 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($331.74).
As a Medicare-enrolled provider, Vanam has provided services to 2,239 Medicare beneficiaries, totaling 3,953 services with total Medicare billing of $306,609. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Richmond, VA
- Active Since 05/10/2013
- Last Updated 11/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841636305
Products in Payments
- ENTRESTO (Drug) $92.19
- XARELTO (Drug) $73.73
- LINQ II (Device) $54.19
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $24.15
- CUBICIN RF (Drug) $15.98
- STIOLTO (Drug) $15.68
- ZERBAXA (Drug) $14.29
- ELIQUIS (Drug) $11.52
- DALVANCE (Drug) $11.03
- Briviact (Drug) $10.55
- LifeVest (Device) $8.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Dr. Erica Gregonis, Md, MD
Internal Medicine — Payments: $314,689
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Dr. Wally Smith, M.d, M.D
Internal Medicine — Payments: $195,657
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406